Last reviewed · How we verify

NCT04848363

Analgesic Effect of Quadratus Lumborum Block in Laparoscopic Hemicolectomy

Status unknown NA Last updated 18 June 2021
What this trial tests

NA trial testing Quadratus lumborum block in Post Operative Pain in 60 participants. Status unknown.

Timeline
16 June 2021
Primary endpoint
30 April 2022
30 May 2022

Quick facts

Lead sponsorPetrovsky National Research Centre of Surgery
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date16 June 2021
Primary completion30 April 2022
Estimated completion30 May 2022
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Petrovsky National Research Centre of Surgery — full company profile →

Who can join

18 and older, any sex, with Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the effectiveness: Quadratus lumborum (QL) block by levobupivacaine with placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Quadratus lumborum block

Trials testing the same drug.

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Other Petrovsky National Research Centre of Surgery trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04848363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing